You were invited to our Q4/2024 Townhall, where we explored our future organization based on what has been agreed upon until then. Updates from our Leadership Team included insights from the PH Strategy Summit, which did initiate discussions on our financials and the strategic mid- and long-term outcomes for Pharma. Additionally, we reflected on the results of the Ownership Pulse (formerly known as Employee Voice), discussed further considerations, and allocated time for a Q&A session. This token serves as appreciation for and proof of your participation. POAP dropped for Bayer DT&IT Pharma Design by stefankai with Canva POAP Terms & Conditions: https://bayer.com/poap Bayer IT POAP Collection: https://collections.poap.xyz/bayer-it/

Another DSO Open MIC session is in the books! Thank you for attending today's afternoon session. These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded. Bayer terms & conditions apply: https://www.bayer.com/poap-tc

Dear CID expert, you have met all Team members today in valuable 90 min. to exchange on DSO & other topics of expertise with the chance to clarify open questions. We are ONE Team and have the same spirit like our peers in the Bayer 04 Leverkusen soccer team. Stay tuned & let's connect! ___ Image created by Stefankai with Midjourney AI and Canva Bayer POAP Term&Conditions: https://bayer.com/poap More info on business use of POAPS at https://go/poap Explore Bayer POAP Collection at https://collections.poap.xyz/bayer

Dear CID Team, I want to extend my heartfelt gratitude to all of you who took the time to participate in our recent CID Townhall Session on December 12, 2023. Your presence, ideas, and engagement made the event truly meaningful. As the year draws to a close, your active involvement in our discussions, reflections, and celebration of our 2023 successes and highlights added immense value. Your contributions helped create a vibrant and enriching exchange. Thank you for sharing your insights and ideas, and for making our Townhall Session a success. Your commitment to our team's growth and collaboration is greatly appreciated. Thank you. Patrick & LT Art by Open AI's Dall-E Text's draft modified by Open AI's ChatGPT

Dear Colleague, Thanks for joining the Berlin 42, Bayer Challenges event. Please notice that after the presentations by the 42 Berlin students and key notes by Bijoy Sagar & Jeanne Kehren, we will have the chance to network in the Mars restaurant nearby the main campus. Since you have officially (and timely ; -) registered, you got a slot at the BBQ following the presentations. Below you find the agenda. 2:00 - 2:05 Event starts – Introduction / The B42BC Team introduces the event and overall agenda 2:05 - 2:35 Keynote by Bijoy Sagar / Bijoy Sagar shares his perspective on fundamental aspects of the IT Industry as for instance, IT skills for the future in Life Science, current talent shortage, Bayer IT ambition, hiring for skills and the relevance of inclusion & diversity 2:35 - 5:30 Presentation by the 42 Berlin Students / Teams present their projects including what they learned, the challenges they faced and their key learnings 5:30 Jeanne Kehren closures the event with her perspective of the collaboration of Bayer and Berlin 42 School including special recognitions to those students who actively participated in the 42BBC projects After the closure of the event, Berlin 42 Students and Bayer Colleagues join a BBQ in Mars. This is a networking event aimed to create the space for 42 Students who participated in the challenges and Bayer employees to exchange and potentially get in contact for future internships. Art created using EZGIF and 3D Gif Maker.

For all Bayverse Squad Members who crossed the finish line for our first big milestone to generate awareness for next level virtual customer engagement.

I visited the Byron Bar at the Bayer Pharmaceuticals Headquarters in Berlin during the spring of 2023. Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.com. Find more information at https://pharma.bayer.com. Facebook: http://www.facebook.com/bayer. Twitter: @BayerPharma. Art by POAP Studio, https://www.poap.studio/. Bayer POAPs terms and conditions: https://bayer.com/poap.